SAPIRSTEIN JAMES
Insider transactions at 3 companies
This page shows all SEC Form 4 filings attributed to SAPIRSTEIN JAMES. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| ONCO | Award / Grant | 3,318 | — | — | Sep 26, 2024 | |
| GRDX | Chairman and CEO | Sale | 1,289 | $1.07 | $1,379 | Jul 2, 2024 |
| GRDX | Chairman and CEO | Sale | 174 | $4.23 | $736 | Apr 1, 2024 |
| GRDX | Chairman and CEO | Sale | 1,887 | $4.96 | $9,360 | Mar 15, 2024 |
| GRDX | Chairman, President and CEO | Sale | 166 | $4.20 | $697 | Jan 12, 2024 |
| GRDX | Chairman, President and CEO | Award / Grant | 20,000 | — | — | Dec 29, 2023 |
| GRDX | President and CEO | Sale | 2,764 | $0.29 | $802 | Oct 4, 2023 |
| GRDX | President and CEO | Sale | 3,349 | $1.54 | $5,157 | Jul 3, 2023 |
| ONCO | Award / Grant | 6,360 | — | — | May 31, 2023 | |
| GRDX | President and CEO | Sale | 3,347 | $2.50 | $8,368 | Apr 3, 2023 |
| GRDX | President and CEO | Award / Grant | 300,000 | — | — | Jan 3, 2023 |
| GRDX | PRESIDENT AND CEO | Award / Grant | 200,000 | — | — | Oct 8, 2019 |
| CTRVP | Chief Executive Officer | Award / Grant | 322,092 | — | — | Jan 3, 2018 |
| CTRVP | Chief Executive Officer | Award / Grant | 141,061 | — | — | Jul 6, 2017 |
| 0001530981 | Award / Grant | 75,000 | $0.79 | $59,250 | Nov 8, 2016 | |
| CTRVP | Chief Executive Officer | Option Exercise | 16,666 | $1.50 | $24,999 | Oct 27, 2016 |
| CTRVP | Chief Executive Officer | Purchase | 10,000 | $1.00 | $10,000 | Feb 18, 2016 |
| CTRVP | Chief Executive Officer | Purchase | 500 | $2.15 | $1,075 | Nov 30, 2015 |
| CTRVP | Chief Executive Officer | Purchase | 2,500 | $1.64 | $4,100 | Nov 23, 2015 |
| 0000849636 | Award / Grant | 2,000,000 | — | — | Sep 3, 2014 | |
| 0001054274 | CEO, Therapeutics Division | Award / Grant | 17,688 | — | — | Jan 9, 2014 |
| 0001054274 | CEO, Alliqua Biomedical, Inc. | Award / Grant | 35,377 | — | — | Nov 27, 2013 |